Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of JELMYTO® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen’s only approved products, and the continued development of UroGen’s pipeline.
- Edison GroupEdison Issues Report on Percheron Therapeutics (PER)Edison issues report on Percheron Therapeutics (ASX: PER)Percheron's clinical strategy has taken an important turn with the announcement of an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), led by Vanderbilt Health. Percheron's contribution will be limited to providing the study drug, a financial grant and advisory support. Following the announcement, the...
- Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 03 09 2026 - (CGWL)FORM 8.3
- Raeliva Announces Rebrand and Expansion of Online Wellness Platform Beyond GLP-1 CareAfter building its initial patient base through online GLP-1 care under the OnlineSemaglutide.org brand, telehealth provider Raeliva is entering its next chapter with an expanded focus on virtual wellness care. While weight management remains part of the platform, the company is broadening its focus to include additional wellness categories, including longevity, hormone health, hair health, and other areas of care subject to individual clinical eligibility.
- From Knee Pain to Better Mobility: Choosing the Best Hospital in Indiathe exceptional facilities offered at best hospitals for total knee replacement in India, which include state-of-the-art equipment, highly skilled surgeons, and strict government regulations regarding patient care.
- Argo Biopharmaceutical Co., LtdArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026- Oral Presentation in Session VI: Hereditary Angioedema — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that updated Phase II data from its ongoing...
- Persica Pharmaceuticals publishes new analyses of antibiotic exposure-response, reinforcing the scientific case for PP353 in vertebrogenic Lumbar Back PainLondon, UK, 04 September - Persica Pharmaceuticals Limited (“Persica”), a clinical-stage biotechnology company developing PP353, a targeted, non-opioid treatment for vertebrogenic Lumbar Back Pain (vLBP), today announces the publication of a study which brings together clinical and pharmacological evidence to address the question of why antibiotic studies in this patient population appear to report variable clinical outcomes.
- ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026EINDHOVEN, the Netherlands, Sept. 04, 2026 -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its first-half 2026 financial results and host a webcast with a comprehensive business update on September 9, 2026.
- Ayurveda You & Me Expands Holistic Wellness Services in CyprusAugust 2026 – Ayurveda You & Me, founded by Ayurvedic health and nutrition consultant, yoga teacher, and sound healing practitioner Miriam Erne, offers a holistic approach to wellbeing that combines ancient wisdom, mindful movement, energy work, and spiritual connection.
- Carestream Healthcare International Enhances DRX‑LC Detector to Level Up Long‑Length Imaging PerformanceCarestream Healthcare International is introducing the latest version of its DRX‑LC Detector, delivering enhanced imaging performance, efficiency, and quality for long‑length imaging across a wide range of exams and clinical environments....
- Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)Companies: Biogen–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on top of standard of care anti-seizure medicines–
- Kaneka Ubiquinol™KANEKA UBIQUINOL™ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026Award Shines Spotlight on Ubiquinol's Role in Mitochondrial Health and Mitoceutical Innovation in the Global Healthspan Movement Seventh International Accolade Affirms Kaneka Ubiquinol™ Leadership in Evidence-Based Mitochondrial Health, Supporting Healthspan from Preconception to Healthy...